Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: DACARBAZINE - THERAPEUTIC USE , . Treffer: 7
2019
Weide, B; Eigentler, T; Catania, C; Ascierto, PA; Cascinu, S; Becker, JC; Hauschild, A; Romanini, A; Danielli, R; Dummer, R; Trefzer, U; Elia, G; Neri, D; Garbe, C
A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients.
Cancer Immunol Immunother. 2019; 68(9):1547-1559
Doi: 10.1007/s00262-019-02383-z
Web of Science
PubMed
FullText
FullText_MUG
2015
Hoffermann, M; Bruckmann, L; Kariem Mahdy, A; Asslaber, M; Payer, F; von Campe, G
Treatment results and outcome in elderly patients with glioblastoma multiforme--a retrospective single institution analysis.
Clin Neurol Neurosurg. 2015; 128(2):60-69
Doi: 10.1016/j.clineuro.2014.11.006
Web of Science
PubMed
FullText
FullText_MUG
2013
Grah, JJ; Katalinic, D; Stern-Padovan, R; Paladino, J; Santek, F; Juretic, A; Zarkovic, K; Plestina, S; Supe, M
Leptomeningeal and intramedullary metastases of glioblastoma multiforme in a patient reoperated during adjuvant radiochemotherapy.
World J Surg Oncol. 2013; 11(1):55-55
Doi: 10.1186/1477-7819-11-55
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2012
Langsenlehner, T; Groll, MJ; Quehenberger, F; Payer, F; Mokry, M; Kapp, KS
Interdisciplinary treatment of glioblastoma: analysis of prognostic factors and treatment results in unselected patients.
Neoplasma. 2012; 59(6):662-668
Doi: 10.4149/neo_2012_084
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2008
Hauschild, A; Dummer, R; Ugurel, S; Kaehler, KC; Egberts, F; Fink, W; Both-Skalsky, J; Laetsch, B; Schadendorf, D
Combined treatment with pegylated interferon-alpha-2a and dacarbazine in patients with advanced metastatic melanoma: a phase 2 study.
Cancer. 2008; 113(6):1404-1411
Doi: 10.1002/cncr.23722
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2006
Schadendorf, D; Ugurel, S; Schuler-Thurner, B; Nestle, FO; Enk, A; Brocker, EB; Grabbe, S; Rittgen, W; Edler, L; Sucker, A; Zimpfer-Rechner, C; Berger, T; Kamarashev, J; Burg, G; Jonuleit, H; Tuttenberg, A; Becker, JC; Keikavoussi, P; Kampgen, E; Schuler, G
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG.
Ann Oncol. 2006; 17(4):563-570
Doi: 10.1093/annonc/mdj138
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
2002
Wack, C; Kirst, A; Becker, JC; Lutz, WK; Brocker, EB; Fischer, WH
Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune response.
Cancer Immunol Immunother. 2002; 51(8):431-439
Doi: 10.1007/s00262-002-0292-4
Web of Science
PubMed
FullText
FullText_MUG